Posted 1/26/2024, 10:17:13 AM
AI Platform Uses Multi-Omic Data to Improve Precision Oncology and Pancreatic Cancer Outcomes
- Applied an AI approach to multi-omic and clinical data to predict survival in pancreatic cancer patients
- Created a tumor-type-agnostic platform to identify biomarkers for precision oncology
- Molecular Twin platform integrates multi-omic data to predict outcomes
- Study provides proteogenomic characterization of pancreatic ductal adenocarcinoma
- Aims to catalyze the vision of democratizing precision oncology worldwide